ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need. Learn more
Launch date
Employees
Market cap
€7.9b
Enterprise valuation
€7.5b (Public information from Feb 2024)
Share price
$31.23 IMGN
Waltham Massachusetts (HQ)
Authorizing premium user...